Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Ko

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Genetics|May 25, 2019
Joint Estimation of Pedigrees and Effective Population Size Using Markov Chain Monte CarloAmy Ko, Rasmus Nielsen
Plos Genetics|August 23, 2017
Composite likelihood method for inferring local pedigreesAmy Ko, Rasmus Nielsen
Psychological Reports|January 30, 2018
Investigating the Relationships Among Resilience, Social Anxiety, and Procrastination in a Sample of College StudentsChen-Yi Amy Ko, Yuhsuan Chang
Scientific Reports|March 23, 2017
Robust Analysis of Fluxes in Genome-Scale Metabolic PathwaysMichael MacGillivray, Amy Ko, Emily Gruber, et al.
Clinical Lung Cancer|May 28, 2016
Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With DiabetesVera Hirsh, Amy Ko, Richard Pilot, et al.
Clinical Lung Cancer|January 10, 2015
Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: analysis of safety and efficacy in patients with renal impairmentCorey J Langer, Vera Hirsh, Amy Ko, et al.
Journal of Osteopathic Medicine|October 14, 2021
Utilizing the Four Tenets of Osteopathic Medicine as an intersectional framework for approaching sexual orientation and gender identity disclosure as a providerTimothy L Counce, Amy Ko, Anthony D Martinez, et al.
BMC Cancer|December 31, 2015
The treatment patterns, efficacy, and safety of nab (®)-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysisCaihua Liang, Ling Li, Cindy Duval Fraser, et al.
Plos Genetics|June 20, 2014
The POU factor ventral veins lacking/Drifter directs the timing of metamorphosis through ecdysteroid and juvenile hormone signalingCeCe Cheng, Amy Ko, Leila Chaieb, et al.
Drug Design, Development and Therapy|June 7, 2018
nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trialCesare Gridelli, Tianlei Chen, Amy Ko, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Genetics|May 25, 2019
Joint Estimation of Pedigrees and Effective Population Size Using Markov Chain Monte CarloAmy Ko, Rasmus Nielsen
Plos Genetics|August 23, 2017
Composite likelihood method for inferring local pedigreesAmy Ko, Rasmus Nielsen
Psychological Reports|January 30, 2018
Investigating the Relationships Among Resilience, Social Anxiety, and Procrastination in a Sample of College StudentsChen-Yi Amy Ko, Yuhsuan Chang
Scientific Reports|March 23, 2017
Robust Analysis of Fluxes in Genome-Scale Metabolic PathwaysMichael MacGillivray, Amy Ko, Emily Gruber, et al.
Clinical Lung Cancer|May 28, 2016
Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With DiabetesVera Hirsh, Amy Ko, Richard Pilot, et al.
Clinical Lung Cancer|January 10, 2015
Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: analysis of safety and efficacy in patients with renal impairmentCorey J Langer, Vera Hirsh, Amy Ko, et al.
Journal of Osteopathic Medicine|October 14, 2021
Utilizing the Four Tenets of Osteopathic Medicine as an intersectional framework for approaching sexual orientation and gender identity disclosure as a providerTimothy L Counce, Amy Ko, Anthony D Martinez, et al.
BMC Cancer|December 31, 2015
The treatment patterns, efficacy, and safety of nab (®)-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysisCaihua Liang, Ling Li, Cindy Duval Fraser, et al.
Plos Genetics|June 20, 2014
The POU factor ventral veins lacking/Drifter directs the timing of metamorphosis through ecdysteroid and juvenile hormone signalingCeCe Cheng, Amy Ko, Leila Chaieb, et al.
Drug Design, Development and Therapy|June 7, 2018
nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trialCesare Gridelli, Tianlei Chen, Amy Ko, et al.
Pageof 3